Analysis of patient access to orphan drugs in Turkey

被引：0
作者：
Güvenç Koçkaya
Sibel Atalay
Gülpembe Oğuzhan
Mustafa Kurnaz
Selin Ökçün
Çiğdem Sar Gedik
Mete Şaylan
Nazlı Şencan
机构：
[1] Econix Research,
[2] Analysis and Consulting Inc.,undefined
[3] Gen Pharmaceuticals and Health Products Inc.,undefined
[4] Ondokuz Mayıs University,undefined
[5] Acıbadem University,undefined
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Rare disease drug; Orphan drug; Orphan drug market;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 51 条
  • [1] Azie N(2012)Rare diseases: the bane of modern society and the quest for cures Clin Pharmacol Ther 92 135-139
  • [2] Vincent J(2013)Australian families living with rare diseases: experiences of diagnosis, health services use and needs for psychosocial support Orphanet J Rare Dis 8 22-245
  • [3] Anderson M(2017)Health-related quality of life among adults with diverse rare disorders Orphanet J Rare Dis 12 177-143
  • [4] Elliott EJ(2006)Rare diseases and orphan drugs Brit J Clin Pharmaco 61 243-52
  • [5] Zurynski YA(2012)Access to orphan drugs in the Middle East: challenge and perspective Intractable Rare Dis Res 1 139-598
  • [6] Bogart KR(2015)Rare diseases and orphan drugs: 500 years ago Orphanet journal of rare diseases 10 161-2570
  • [7] Irvin VL(2014)An overview of the orphan medicines market in Turkey Value Health Reg Issues 4 47-153
  • [8] Aronson JK(2013)Insurance companies’ perspectives on the orphan drug pipeline Am Health Drug Benefits 6 589-273
  • [9] Almalki ZS(2016)Financial and legislative aspects of drug development of orphan diseases on the European market: a systematic review Appl Econ 48 2562-151
  • [10] Alahmari AK(2013)Orphan drug regulations in Turkey J Pharm Health Serv Res 4 151-1443
123456